NASDAQ:BRKR
Bruker Corporation Stock News
$70.09
-8.94 (-11.31%)
At Close: May 02, 2024
Top 5 Large-Cap Stocks Set to Beat on Q4 Earnings This Week
09:47am, Tuesday, 07'th Feb 2023
Five large-cap companies are set to beat fourth-quarter earnings estimates this week. These are: PRU, OMC, YUM, SLF, and BRKR.
Ranking The Diversified Healthcare Giants
10:53pm, Sunday, 22'nd Jan 2023
The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
Bruker Corp.: My Top Ranked Holding In Laboratory Analytical Instruments
03:50am, Thursday, 19'th Jan 2023
Bruker offers a range of advantages over peers: profitability, value, growth, and more. As such, the company is well-positioned to provide strong returns in the future.
Bruker's (BRKR) New Tie-Up to Expand Its U.S. CRO Business
03:03pm, Thursday, 05'th Jan 2023
Bruker's (BRKR) latest partnership is expected to expand its CRO business in the United States, benefiting more biopharma and diagnostics companies using unbiased proteomics for decision-making.
Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 21'st Dec 2022
BILLERICA, Mass.--( BUSINESS WIRE )--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 41st annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairma
Bruker Corporation (BRKR) Q3 2022 Earnings Call Transcript
03:24pm, Saturday, 05'th Nov 2022
Bruker Corporation (NASDAQ:BRKR ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Justin Ward - Senior Director of Investor Relations & Corporate Development Frank La
Bruker Announces Date and Time of Third Quarter 2022 Earnings Release and Webcast
04:01pm, Friday, 21'st Oct 2022
BILLERICA, Mass.
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
02:11pm, Friday, 21'st Oct 2022 Benzinga
Upgrades
SVB Leerink upgraded the previous rating for Moderna Inc (NASDAQ:MRNA) from Underperform to Market Perform. Moderna earned $5.24 in the second quarter, compared to $6.46 in the year-ago quart
BD's (BDX) New Cloud Software Solution to Boost Lab Workflow
01:45pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
BD's (BDX) latest launch is expected to provide scientists with an integrated ecosystem that enables optimization of panel design, collaboration and analysis.
Bruker (BRKR) Gains From New Product Bookings Amid Competition
03:33pm, Friday, 23'rd Sep 2022 Zacks Investment Research
Bruker's (BRKR) revenue recognition from one gigahertz class NMR system and continued uptake of the timsTOF platform hold promise.
Bruker (BRKR) Gains From New Product Bookings Amid Competition
12:47pm, Friday, 23'rd Sep 2022
Bruker's (BRKR) revenue recognition from one gigahertz class NMR system and continued uptake of the timsTOF platform hold promise.
Here's Why You Should Retain Bruker (BRKR) Stock for Now
05:15pm, Monday, 05'th Sep 2022 Zacks Investment Research
Investors are optimistic about Bruker's (BRKR) segmental results and robust bookings and backlog growth.
Here's Why You Should Retain Bruker (BRKR) Stock for Now
02:18pm, Monday, 05'th Sep 2022
Investors are optimistic about Bruker's (BRKR) segmental results and robust bookings and backlog growth.
Why Is Bruker (BRKR) Down 11.3% Since Last Earnings Report?
03:31pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bruker (BRKR) Debuts Innovations for Proteomics & Metabolomics
05:46pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Bruker's (BRKR) novel nanoElute 2 and next-generation MetaboScape 2023 release are likely to offer enhanced workflows for proteomics and metabolomics applications.
